Raymond James & Associates’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.13M | Buy |
31,316
+15,138
| +94% | +$2.24M | ﹤0.01% | 1644 |
|
|
2024
Q2 | $2.24M | Sell |
16,178
-18,430
| -53% | -$2.54M | ﹤0.01% | 2093 |
|
|
2024
Q1 | $4.78M | Buy |
34,608
+232
| +0.7% | +$27.8K | ﹤0.01% | 1613 |
|
|
2023
Q4 | $3.6M | Buy |
34,376
+19,759
| +135% | +$1.83M | ﹤0.01% | 1736 |
|
|
2023
Q3 | $1.38M | Sell |
14,617
-740
| -5% | -$75.5K | ﹤0.01% | 2248 |
|
|
2023
Q2 | $1.54M | Sell |
15,357
-2,537
| -14% | -$235K | ﹤0.01% | 2223 |
|
|
2023
Q1 | $1.45M | Sell |
17,894
-1,446
| -7% | -$116K | ﹤0.01% | 2222 |
|
|
2022
Q4 | $1.44M | Sell |
19,340
-2,496
| -11% | -$194K | ﹤0.01% | 2204 |
|
|
2022
Q3 | $1.81M | Buy |
21,836
+2,782
| +15% | +$244K | ﹤0.01% | 2033 |
|
|
2022
Q2 | $1.52M | Sell |
19,054
-3,597
| -16% | -$364K | ﹤0.01% | 2181 |
|
|
2022
Q1 | $2.56M | Buy |
22,651
+865
| +4% | +$97.1K | ﹤0.01% | 1959 |
|
|
2021
Q4 | $2.48M | Sell |
21,786
-31,232
| -59% | -$3.36M | ﹤0.01% | 2016 |
|
|
2021
Q3 | $6.16M | Buy |
53,018
+172
| +0.3% | +$21.5K | 0.01% | 1361 |
|
|
2021
Q2 | $6.36M | Sell |
52,846
-8,724
| -14% | -$1.03M | 0.01% | 1332 |
|
|
2021
Q1 | $6.63M | Sell |
61,570
-19,638
| -24% | -$2.18M | 0.01% | 1256 |
|
|
2020
Q4 | $9.53M | Buy |
81,208
+16,283
| +25% | +$1.66M | 0.01% | 980 |
|
|
2020
Q3 | $5.56M | Buy |
64,925
+318
| +0.5% | +$27.2K | 0.01% | 1164 |
|
|
2020
Q2 | $5.11M | Sell |
64,607
-16,498
| -20% | -$1.29M | 0.01% | 1165 |
|
|
2020
Q1 | $6.17M | Sell |
81,105
-28,756
| -26% | -$2.26M | 0.01% | 941 |
|
|
2019
Q4 | $8.24M | Sell |
109,861
-27,875
| -20% | -$1.85M | 0.01% | 983 |
|
|
2019
Q3 | $7.86M | Sell |
137,736
-17,915
| -12% | -$1.04M | 0.01% | 978 |
|
|
2019
Q2 | $8.76M | Buy |
155,651
+881
| +0.6% | +$45.6K | 0.01% | 926 |
|
|
2019
Q1 | $8.4M | Buy |
154,770
+13,561
| +10% | +$751K | 0.01% | 900 |
|
|
2018
Q4 | $7.27M | Buy |
141,209
+54,435
| +63% | +$3.49M | 0.01% | 910 |
|
|
2018
Q3 | $6.22M | Sell |
86,774
-19,298
| -18% | -$1.36M | 0.01% | 1091 |
|
|
2018
Q2 | $7.37M | Buy |
106,072
+11,637
| +12% | +$778K | 0.01% | 968 |
|
|
2018
Q1 | $6.23M | Sell |
94,435
-30,786
| -25% | -$2.26M | 0.01% | 1022 |
|
|
2017
Q4 | $9.05M | Sell |
125,221
-42,052
| -25% | -$2.59M | 0.02% | 809 |
|
|
2017
Q3 | $9.93M | Buy |
167,273
+17,367
| +12% | +$1.05M | 0.02% | 740 |
|
|
2017
Q2 | $9.71M | Sell |
149,906
-23,990
| -14% | -$1.59M | 0.02% | 715 |
|
|
2017
Q1 | $11.8M | Sell |
173,896
-16,710
| -9% | -$1.11M | 0.03% | 581 |
|
|
2016
Q4 | $12.2M | Buy |
190,606
+51,015
| +37% | +$3.18M | 0.03% | 541 |
|
|
2016
Q3 | $9.22M | Buy |
139,591
+58,992
| +73% | +$4.15M | 0.03% | 645 |
|
|
2016
Q2 | $6.23M | Sell |
80,599
-1,401
| -2% | -$106K | 0.02% | 747 |
|
|
2016
Q1 | $6.02M | Sell |
82,000
-71,248
| -46% | -$4.81M | 0.02% | 734 |
|
|
2015
Q4 | $10.7M | Sell |
153,248
-43,026
| -22% | -$3.15M | 0.04% | 499 |
|
|
2015
Q3 | $14.2M | Sell |
196,274
-11,353
| -5% | -$880K | 0.06% | 362 |
|
|
2015
Q2 | $16.5M | Sell |
207,627
-17,340
| -8% | -$1.42M | 0.06% | 345 |
|
|
2015
Q1 | $18.3M | Buy |
224,967
+33,131
| +17% | +$2.54M | 0.08% | 271 |
|
|
2014
Q4 | $14.5M | Sell |
191,836
-26,686
| -12% | -$2.01M | 0.07% | 301 |
|
|
2014
Q3 | $16M | Buy |
218,522
+30,790
| +16% | +$2.25M | 0.09% | 233 |
|
|
2014
Q2 | $13.6M | Sell |
187,732
-2,913
| -2% | -$203K | 0.08% | 254 |
|
|
2014
Q1 | $13.1M | Buy |
190,645
+61,951
| +48% | +$4.12M | 0.09% | 245 |
|
|
2013
Q4 | $8.15M | Buy |
128,694
+105,069
| +445% | +$6.17M | 0.06% | 361 |
|
|
2013
Q3 | $1.34M | Sell |
23,625
-35,457
| -60% | -$2.03M | 0.01% | 1087 |
|
|
2013
Q2 | $3.57M | Buy |
+59,082
| New | +$3.69M | 0.03% | 558 |
|
Other funds holding DVA
GCM
Raymond James & Associates's DVA Position: Q3 2024 in Review
Raymond James & Associates increased its DaVita (DVA) stake by 94% in Q3 2024, buying an estimated $2.24M and bringing the position to 31,316 shares worth $5.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1644.
Raymond James & Associates first reported a position in DVA in Q2 2013 and has held it in 46 quarters since. The position peaked at $18.3M in Q1 2015. 600 funds tracked by Wall St. Rank hold DVA as of Q3 2024.
- Raymond James & Associates held 31,316 shares of DaVita worth $5.13M as of Q3 2024.
- Raymond James & Associates bought 15,138 DaVita shares in Q3 2024, an estimated $2.24M.
- DaVita made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1644 holding.
- Raymond James & Associates first reported a position in DaVita in Q2 2013 and has held it in 46 quarters since.
- Raymond James & Associates's DaVita position peaked at $18.3M in Q1 2015.
- 600 funds tracked by Wall St. Rank held DaVita as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.